[go: up one dir, main page]

IS7978A - Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum - Google Patents

Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum

Info

Publication number
IS7978A
IS7978A IS7978A IS7978A IS7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A IS 7978 A IS7978 A IS 7978A
Authority
IS
Iceland
Prior art keywords
preparation
basic compound
alkaline compounds
additional salts
polyacidic
Prior art date
Application number
IS7978A
Other languages
English (en)
Inventor
Shibuya Kimiyuki
Ohgiya Tadaaki
Matsuda Takayuki
Original Assignee
Kowa Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co., Ltd. filed Critical Kowa Co., Ltd.
Publication of IS7978A publication Critical patent/IS7978A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS7978A 2003-02-28 2005-08-12 Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum IS7978A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003052700 2003-02-28
PCT/JP2004/002375 WO2004076441A1 (ja) 2003-02-28 2004-02-27 多酸性塩基化合物の酸付加塩の製造方法

Publications (1)

Publication Number Publication Date
IS7978A true IS7978A (is) 2005-08-12

Family

ID=32923406

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7978A IS7978A (is) 2003-02-28 2005-08-12 Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum

Country Status (21)

Country Link
US (2) US7750150B2 (is)
EP (1) EP1598346B1 (is)
JP (2) JP4594863B2 (is)
KR (1) KR101106127B1 (is)
CN (2) CN1753886B (is)
AT (1) ATE554083T1 (is)
AU (1) AU2004215523B2 (is)
BR (1) BRPI0407908A (is)
CA (1) CA2516822C (is)
DK (1) DK1598346T3 (is)
EA (1) EA009045B1 (is)
ES (1) ES2384517T3 (is)
IL (1) IL170093A (is)
IS (1) IS7978A (is)
MX (1) MXPA05009129A (is)
MY (1) MY140618A (is)
NO (1) NO331272B1 (is)
NZ (1) NZ541716A (is)
PL (1) PL378292A1 (is)
TW (2) TWI355384B (is)
WO (1) WO2004076441A1 (is)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound
NZ544803A (en) 2003-08-29 2009-11-27 Kowa Co Method of stabilizing lipid-rich plaque and method of preventing rupture thereof
TW200619204A (en) * 2004-12-10 2006-06-16 Kowa Co Method for reduction, stabilization and prevention of rupture of lipid rich plaque
CN101253166B (zh) 2005-08-30 2013-07-10 旭化成制药株式会社 磺酰胺化合物
WO2008105058A1 (ja) * 2007-02-27 2008-09-04 Asahi Kasei Pharma Corporation スルホンアミド化合物
JP5313125B2 (ja) 2007-02-28 2013-10-09 旭化成ファーマ株式会社 スルホンアミド誘導体
ES2396795T3 (es) * 2007-07-02 2013-02-27 Asahi Kasei Pharma Corporation Compuesto de sulfonamida y cirstal del mismo
JP5631738B2 (ja) * 2007-11-30 2014-11-26 オプティチューン オサケ ユキチュア 新規シロキサンポリマー組成物
CN102711763A (zh) * 2009-12-29 2012-10-03 兴和株式会社 口服用医药组合物
EP2520299A1 (en) * 2009-12-29 2012-11-07 Kowa Co., Ltd. Solid pharmaceutical composition for oral administration
KR20130113921A (ko) 2010-05-19 2013-10-16 코와 가부시키가이샤 비알코올성 지방성 간염의 예방 및/또는 치료제
EP4606784A3 (en) * 2015-06-17 2025-11-05 Gilead Sciences, Inc. Co-crystals, salts and solid forms of tenofovir alafenamide
JPWO2018092765A1 (ja) * 2016-11-15 2019-10-17 学校法人同志社 経鼻投与用医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112152A (en) * 1994-12-26 2000-11-21 Identa Ltd Process and test kit for cocaine detection
DE69828276T2 (de) * 1997-05-26 2005-12-15 Kowa Co., Ltd., Nagoya Neue cyclische Diaminverbindungen und Heilmittel das diese enthält
US6969711B2 (en) * 1997-05-26 2005-11-29 Kowa Company, Ltd. Cyclic diamine compounds and medicine containing the same
GB9826180D0 (en) * 1998-11-30 1999-01-20 Smithkline Beecham Plc Novel process
US20060165605A1 (en) * 2001-12-28 2006-07-27 Ye-Mon Chen Process to regenerate fcc spent catalyst
AU2003289039A1 (en) * 2002-12-12 2004-06-30 Kowa Co., Ltd. Hydroxyalkylated cyclic diamine compound
MY140849A (en) * 2003-07-07 2010-01-29 Kowa Co 2, 4-bis (trifluoroethoxy) pyridine compound and drug containing the compound

Also Published As

Publication number Publication date
PL378292A1 (pl) 2006-03-20
EA200501379A1 (ru) 2006-02-24
US7750150B2 (en) 2010-07-06
TWI374136B (en) 2012-10-11
EA009045B1 (ru) 2007-10-26
EP1598346B1 (en) 2012-04-18
NZ541716A (en) 2007-11-30
EP1598346A4 (en) 2007-08-15
JP5180998B2 (ja) 2013-04-10
AU2004215523A1 (en) 2004-09-10
NO20054100D0 (no) 2005-09-02
NO331272B1 (no) 2011-11-14
US20060079688A1 (en) 2006-04-13
CN102702171B (zh) 2014-09-10
AU2004215523B2 (en) 2009-07-16
IL170093A (en) 2012-02-29
CA2516822C (en) 2012-09-25
MY140618A (en) 2009-12-31
EP1598346A1 (en) 2005-11-23
JPWO2004076441A1 (ja) 2006-06-01
DK1598346T3 (da) 2012-05-29
JP4594863B2 (ja) 2010-12-08
TW201202218A (en) 2012-01-16
TWI355384B (en) 2012-01-01
BRPI0407908A (pt) 2006-02-14
US8518936B2 (en) 2013-08-27
US20100234599A1 (en) 2010-09-16
CN102702171A (zh) 2012-10-03
ES2384517T3 (es) 2012-07-06
WO2004076441A1 (ja) 2004-09-10
TW200504052A (en) 2005-02-01
MXPA05009129A (es) 2005-10-20
NO20054100L (no) 2005-09-22
ATE554083T1 (de) 2012-05-15
JP2010235635A (ja) 2010-10-21
CA2516822A1 (en) 2004-09-10
CN1753886A (zh) 2006-03-29
KR101106127B1 (ko) 2012-01-20
CN1753886B (zh) 2012-07-18
KR20050105218A (ko) 2005-11-03

Similar Documents

Publication Publication Date Title
DK1781683T3 (da) Fremgangsmåde til fremstilling af 17-vinyl-triflater som halvfabrikata
IS7978A (is) Aðferð til að framleiða súr viðbótarsölt af fjölsýrðum basískum samböndum
ATE497957T1 (de) Pyridinderivate als fungizide verbindungen
CR9369A (es) Compuestos de peridil acido acetico
BRPI0514543A (pt) sais de metanossulfonato de abiraterona-3-ésteres e recuperação de sais de abiraterona-3-ésteres de solução em éter de terc-butila de metila
EA200970569A1 (ru) Применимые в качестве гербицидных соединений пиридопиразиновые производные
ATE451380T1 (de) Verfahren zur herstellung von bisphosphonsäureverbindungen
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
DK1881957T3 (da) Fremgangsmåde til fremstilling af biproduktfattige methylglycin-N,N-diedikkesyre-trialkalimetalsalte
IL178771A0 (en) 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides
ATE420875T1 (de) Verfahren zur herstellung von 5-(4-ä4-(5-cyano-3- indolyl)-butylü-1-piperazinyl)-benzofuran-2- carboxamid
EA201001252A1 (ru) Способ получения производных 3,6-дигидро-1,3,5-триазина
FR2846325B1 (fr) Nouveau procede de preparation d'un intermediaire de synthese de pesticide
DK1581504T3 (da) Fremgangsmåde til fremstilling af subsituterede imidazolderivater og intermediater anvendt i fremgangsmåden
NO20053208D0 (no) Metode for reduktiv dehalogenering.
WO2007144363A3 (en) Process for the preparation of 6-alpha, 9-alpha-difluoro-17-alpha - ((2-furanylcarbonyl)oxy)-11-beta -hydroxy-16-alpha -methyl-s-oxo-androsta-1,4-diene-17-beta- -carbothioic acid s-fluoromethyl
DE50304869D1 (de) Verfahren zur herstellung einer spezifischen kristallmodifikation von 2-(2-chlor-4-mesyl-benzoyl)-cyclohexan-1,3-dion
RU2005105549A (ru) Способ получения коньюгатов гепарина
TW200700370A (en) Producing method of haloalkylether compounds
TW200621691A (en) Chiral 3-halophthalic acid derivatives
RU2018123595A (ru) Способ получения хелатообразующего агента
PL407772A1 (pl) Krystaliczna forma kompleksu trihydrat chlorku [di(2-amino-5-guanidynopentano)(4,4'-dipirydylo) miedzi (II)] i sposób jej wytwarzania
UY27120A1 (es) Procedimiento para la preparación de la sal del ácido (d)-tartárico
TH108864A (th) กระบวนการสำหรับการเตรียม d,l-2-ไฮดรอกซี-4-อัลคิลไธโอบิวทิริกแอซิด
NO20002497L (no) Fremgangsmåte for fremstilling av hydroksyforbindelser